Defence Science and Technology Laboratory (DSTL), Porton Down, Salisbury, Wilts SP4 0JQ, UK.
J Immunol Res. 2014;2014:395302. doi: 10.1155/2014/395302. Epub 2014 May 7.
This review considers the steps required to evaluate a candidate biodefense vaccine or therapy as it emerges from the research phase, in order to transition it to development. The options for preclinical modelling of efficacy are considered in the context of the FDA's Animal Rule.
本综述考虑了在候选生物防御疫苗或疗法从研究阶段出现时,为将其推向开发阶段而需要采取的评估步骤。本文还考虑了在 FDA 的动物规则背景下,对疗效进行临床前建模的选择。